The Leading Beyond The Lab Podcast is hosted by Lawrence Rose, one of the Directors at ARTO, a talent solutions agency specialising in leadership roles within the Life Sciences sector globally.
This podcast provides insightful discussions with industry experts, leaders and innovators, shaping the future in drug development and clinical devices. We talk with biotechnology and/or pharmaceutical executives, and find out from them their stories, personal career development and analyse their opinion on how to become successful in this space. We talk on a range of topics including soft skills, oncology, leadership, micromanagement, investment, cardiology, AI, dementia, addiction, hematology, dermatology, and much more.
This podcast applies broadly to all types of connections in the Life Sciences Industry, and aims to educate and inspire those who want to excel in leadership.
Hosted on Acast. See acast.com/privacy for more information.
The Leading Beyond The Lab Podcast is hosted by Lawrence Rose, one of the Directors at ARTO, a talent solutions agency specialising in leadership roles within the Life Sciences sector globally.
This podcast provides insightful discussions with industry experts, leaders and innovators, shaping the future in drug development and clinical devices. We talk with biotechnology and/or pharmaceutical executives, and find out from them their stories, personal career development and analyse their opinion on how to become successful in this space. We talk on a range of topics including soft skills, oncology, leadership, micromanagement, investment, cardiology, AI, dementia, addiction, hematology, dermatology, and much more.
This podcast applies broadly to all types of connections in the Life Sciences Industry, and aims to educate and inspire those who want to excel in leadership.
Hosted on Acast. See acast.com/privacy for more information.
If you're in biotech, immunology, or drug development - this is the episode you’ve been waiting for.
We’re joined by Dr. Bhaskar Srivastava, Chief Medical Officer at Triveni Bio, whose career has spanned over 10 years across J&J, Nimbus, and now Triveni Bio, one of the most ambitious autoimmune biotech startups on the scene.
In this episode, Bhaskar dives deep into:
· How Triveni is building a first-in-class pipeline targeting the kallikrein system - a bold bet to treat severe skin and inflammatory conditions by tackling novel biology.
· What it means to be a founder’s CMO, and how great science needs the right development strategy to make a difference.
· Candid stories from his past roles at Nimbus (which sold its TYK2 program to Takeda for $4B) and Janssen, where he helped guide first-in-class therapies from Phase 1 to pivotal trials.
· Why bispecifics may be risky but worth it, and how Triveni is using novel biologics to crack tough diseases like atopic dermatitis.
· Advice for executives: how to balance ambition and discipline, when to say no, and why choosing the right team members matters as much as the science.
🎙 Bhaskar doesn’t just talk science - he connects molecular biology to patient need, clinical strategy, and company vision with clarity and purpose.
Follow ARTO
LinkedIn: https://www.linkedin.com/company/artotalent
Spotify: Leading Beyond The Lab
Instagram: Instagram (@arto.talent)
TikTok: artotalent on TikTok
Apple Podcasts: Leading Beyond The Lab
Website: Home
Youtube: ARTO Recruitment
Bhaskar Srivastava
CMO at Triveni Bio
LinkedIn: https://www.linkedin.com/in/bhaskar-srivastava-355a9ab1/
Lawrence Rose
Co-Founder + Talent Solutions Director At ARTO
LinkedIn: https://www.linkedin.com/in/lawrencerose/
Timestamps:
00:00 Career Beginnings
15:44 Success & Growth in Biotech
28:43 Investing in Biotech
34:23 The Future of Dermatology & Triveni Bio
#LeadingBeyondTheLab #ARTOTalent #Biotechnology
Hosted on Acast. See acast.com/privacy for more information.